If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer for Subscription and Publication of Prospectus

24 Aug 2023 16:18

Offer for Subscription and Publication of Prospectus

Seneca Growth Capital VCT Plc (the "Company")

24 August 2023

SENECA GROWTH CAPITAL VCT PLC(the “Company”)

Offer for Subscription and Publication of Prospectus

Seneca Growth Capital VCT Plc (LSE: SVCT) is pleased to announce that it has published a prospectus in relation to an offer for subscription for B ordinary shares of 1p each in the Company to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the "Offer").

The Offer will open on 24 August 2023 and is expected to close no later than 5.00 p.m. on 5 April 2024 in relation to the tax year 2023/24 and will close at 5.00 p.m. on 16 August 2024 in relation to the tax year 2024/25 (unless, in either case, the Offer has been fully subscribed before these dates or closed earlier at the discretion of the Directors).

Pursuant to an Offer Agreement dated 23 August 2023 relating to the Offer between, among others, the Company and Seneca Partners Limited ("SPL"), the investment manager of the Company, SPL as the promoter of the Offer will receive a promoter fee of up to 5.5% of the application amount in relation to each accepted application (with reductions to the fee applying in certain cases (for instance, early applications under the Offer)). The aggregate amount of promoter fee to be paid to SPL under the Offer Agreement shall not exceed £600,000.

As SPL is a related party of the Company under the Listing Rules, the payment of a promoter fee by the Company to SPL, is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Prospectus, free of charge, private investors and financial advisers should contact Seneca Partners Limited on 01942 271 746 or at 9 The Parks, Haydock WA12 0JQ. A downloadable version of the prospectus will also be available from the Company's website: https://senecavct.co.uk/current-offer/. A copy of the Prospectus will shortly be provided to all shareholders of the Company, depending on their expressed communication preferences.

The Prospectus has been approved by the Financial Conduct Authority and will shortly be available to view at the online viewing facility of the National Storage Mechanism at the following website address: data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.comRichard Manley, Seneca Growth Capital VCT Plc at richard.manley@senecapartners.co.uk

Any enquiries in respect of the Offer should be directed to:

Siobhan PycroftSeneca Partners Limited01942 295 981siobhan.pycroft@senecapartners.co.uk

Date   Source Headline
31st Mar 20205:30 pmGNWNet Asset Value(s)
26th Mar 20204:31 pmGNWAGM Venue Change
13th Mar 20204:14 pmGNWInterim Dividend
10th Mar 20202:28 pmGNWIssue of Equity
10th Mar 20207:00 amGNWB Share Net Asset Value
3rd Mar 20204:30 pmGNWIssue of Supplementary Prospectus
27th Feb 20207:00 amGNWFinal Results
9th Dec 20195:45 pmGNWDirectorate Change
27th Nov 20192:45 pmGNWIssue of Equity
20th Nov 20194:00 pmGNWDuplicate: Second Interim Dividend
28th Oct 20197:00 amGNWSecond interim dividend
10th Oct 20196:30 pmGNWDirector/PDMR Shareholding
8th Oct 20191:55 pmGNWIssue of Equity
8th Oct 20197:00 amGNWUpdate for the quarter ended 30 September 2019
17th Jul 20198:00 amGNWCorrection: Offer for Subscription
16th Jul 20195:27 pmGNWOffer for Subscription
10th Jul 20195:20 pmGNWHalf-year report
18th Jun 20199:16 amRNSHolding(s) in Company
10th Jun 20196:14 pmRNSResult of AGM
16th May 20197:00 amRNSSecond Interim Dividend
29th Apr 20198:52 amRNSFinal Results
25th Apr 20197:00 amRNSNet Asset Value(s)
5th Apr 201912:47 pmRNSIssue of Equity
3rd Apr 201912:46 pmRNSIssue of Equity
29th Mar 20195:20 pmRNSRevised timetable
13th Mar 201912:03 pmRNSExtension of Offer
7th Mar 20193:22 pmRNSIssue of Equity
6th Mar 201910:30 amRNSInterim Dividend
6th Mar 20198:39 amRNSNet Asset Value(s)
28th Dec 20187:00 amRNSDividend Declaration
19th Dec 20182:21 pmRNSIssue of Equity
18th Dec 20189:56 amRNSUpdate on Hallmarq
17th Dec 20184:43 pmRNSReduction of Capital
29th Nov 20181:53 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNSUpdate for the quarter ended 30 September 2018
27th Sep 201810:59 amRNSIssue of Equity
23rd Apr 201812:43 pmRNSHolding(s) in Company
22nd May 201712:59 pmRNSHolding(s) in Company
24th Feb 201610:42 amRNSScancell to present at Biotech Capital
16th Feb 20159:47 amRNSHoldings in Company
24th Oct 20133:53 pmRNSInterim Management Statement
22nd Mar 20127:00 amRNSFinal Results
29th Oct 201011:18 amRNSInterim Management Statement
7th Sep 201011:34 amRNSDirector's Dealings
5th Aug 20107:00 amRNSHalf Yearly Report
7th May 20107:00 amRNSResults of AGM and IMS to 31 March 2010
31st Mar 20104:48 pmRNSAnnual Financial Report
22nd Jan 201012:26 pmRNSDeclaration of Interim Dividend
24th Sep 20099:43 amRNSDirector's Dealing
22nd Sep 200910:10 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.